• Fluconazole: Optimizing Fungal Cytochrome P450 Inhibition As

  2026-07-15

  Fluconazole, a triazole antifungal, is an essential tool in dissecting fungal cytochrome P450 enzyme 14α-demethylase inhibition, enabling advanced antifungal susceptibility testing and resistance modeling. This article delivers actionable workflows, troubleshooting strategies, and translates recent research innovations into practical laboratory protocols for both in vitro and in vivo fungal pathogenesis studies.

• Irinotecan (CPT-11): Advanced Mechanisms and Hepatotoxicity

  2026-07-15

  Explore the dual role of Irinotecan (CPT-11) in colorectal cancer research and its impact on the gut–liver axis. This article delivers a deep scientific analysis, integrating recent findings on DNA damage induction and chemotherapy-associated hepatotoxicity.

• 2'3'-cGAMP (Sodium Salt): Precision Tool for STING Pathway A

  2026-07-14

  2'3'-cGAMP (sodium salt) from APExBIO enables robust, reproducible activation of the cGAS-STING pathway—delivering unrivaled sensitivity for immunology, cancer, and antiviral workflows. This guide decodes advanced applications, protocol optimization, and troubleshooting strategies to harness its full experimental potential.

• Estradiol Benzoate as an Estrogen Receptor Alpha Agonist: Ap

  2026-07-14

  Estradiol Benzoate empowers precise modeling of estrogen receptor alpha signaling, excelling in hormone receptor binding assays and cell-based workflows. This guide details advanced protocol strategies, comparative applications, and solutions to common experimental pitfalls—helping researchers maximize reproducibility and data integrity.

• SGI-1027: DNA Methyltransferase Inhibitor for Epigenetic Can

  2026-07-13

  SGI-1027, a potent DNA methyltransferase inhibitor from APExBIO, empowers researchers to reactivate tumor suppressor genes and dissect cancer epigenetics with mechanistic precision. This guide translates breakthrough findings and proven workflows into actionable protocols for robust DNA methylation inhibition and tumor biology research.

• Honokiol: Precision NF-κB Pathway Inhibition in Cancer Assay

  2026-07-13

  Honokiol, a bioactive small molecule from APExBIO, delivers robust NF-κB pathway inhibition and oxidative stress modulation for advanced cancer research workflows. This article outlines optimized protocols, practical troubleshooting, and cutting-edge applications that leverage Honokiol’s unique biochemical properties to enhance in vitro drug response evaluation.

• Deoxynivalenol Hepatotoxicity: Mitophagy Overactivation & Nr

  2026-07-12

  This study reveals that deoxynivalenol (DON), a widespread mycotoxin, induces liver injury by overactivating PINK1/Parkin-mediated mitophagy and inhibiting the p62-Keap1-Nrf2 cytoprotective pathway. These mechanistic insights clarify the molecular basis of DON hepatotoxicity and highlight emerging intervention targets for translational liver injury models.

• Redefining Synaptic Modulation: CGP 55845 Hydrochloride in T

  2026-07-10

  This thought-leadership article investigates the mechanistic and translational value of CGP 55845 hydrochloride—a potent, selective GABAB receptor antagonist—in the context of astrocyte-mediated synaptic transmission and cognitive function. By linking recent advances in dentate gyrus GAT-3 research to actionable in vitro assay design, we provide strategic guidance for translational researchers aiming to unravel glia-neuron interactions using state-of-the-art pharmacological tools. The discussion bridges mechanistic insight, protocol optimization, and the evolving competitive landscape, while highlighting APExBIO’s CGP 55845 hydrochloride as a benchmark compound for next-generation neuroscience discovery.

• AG-126 (Tyrphostin AG-126): Applied ERK1/2 Inhibition Workfl

  2026-07-09

  AG-126 (Tyrphostin AG-126) empowers researchers with precise, selective inhibition of ERK1/2, enabling robust dissection of MAPK/ERK signaling in both neurodevelopmental and inflammatory models. This guide translates recent advances—especially in the context of repetitive behavior and neuroinflammation—into actionable protocols, troubleshooting strategies, and workflow enhancements for maximal assay clarity.

• Chloramphenicol in Plasmid Selection: Protocols & Innovation

  2026-07-09

  Chloramphenicol, a precise bacterial protein synthesis inhibitor, is pivotal for high-stringency plasmid selection and advanced resistance gene transfer workflows in molecular biology. This article bridges cutting-edge findings on carbapenemase-encoding gene transmission with optimized, actionable protocols using APExBIO’s ultra-pure Chloramphenicol.

• Intravesical p21 mRNA–LNPs for Localized Bladder Cancer Ther

  2026-07-08

  This study introduces a non-viral approach using p21 mRNA-loaded lipid nanoparticles (LNPs) for intravesical delivery in bladder cancer. The findings demonstrate effective tumor suppressor replacement, robust anti-tumor activity, and translational potential for localized therapy.

• TaqI Restriction Endonuclease: Fast DNA Digestion Protocols

  2026-07-08

  TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific DNA cleavage for molecular biology workflows that require fast, reproducible digestion of plasmid, PCR, or genomic DNA. It is not suited for diagnostic or medical applications. Use this enzyme when speed and sticky-end generation are workflow priorities.

• SGI-1027: Mechanistic Insights and Synergies in Cancer Epige

  2026-07-07

  Explore the molecular mechanism and translational potential of SGI-1027, a potent DNA methyltransferase inhibitor, in advanced cancer epigenetics. This article uniquely analyzes SGI-1027’s synergy with targeted therapies and its impact on practical assay design.

• Oleic Acid (C18:1(9Z)): Strategic Leverage in Translational

  2026-07-07

  Oleic Acid (C18:1(9Z)) serves as a mechanistically rich tool for translational researchers seeking to model lipid metabolism, inflammation, and cell proliferation. This article synthesizes recent advances—including evidence from hepatic ischemia-reperfusion injury (HIRI) models and in vitro assays—to offer actionable guidance on assay optimization, mechanistic study design, and the translational trajectory of fatty acid signaling research. By integrating APExBIO’s reagent-grade Oleic Acid and cross-referencing contemporary protocol literature, the discussion reveals new strategic frontiers beyond standard product notes.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-07-06

  Harper et al. reveal that cell death following RNA polymerase II (Pol II) inhibition is not simply a passive consequence of lost transcription, but an active, regulated apoptotic response triggered by the loss of hypophosphorylated Pol IIA. This mechanism redefines how the integrity of the transcriptional apparatus is monitored and highlights new avenues for DNA damage response research and cancer therapy targeting.

16213 records 1/1081 page Next 12345 下5页 Last page